Researchers found that weight management through GLP-1 therapies may improve ovulation and reproductive markers in women with polycystic ovary syndrome (PCOS), while also showing potential benefits for testosterone levels and sperm quality in men with obesity
doi: 10.1111/dom.13029
A good skin-care routine is, of course, the first step to tackling either
( 10.1001/jama.2015.9676) [DOI] [PubMed] [Google Scholar] 80.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TAet al
The cardiovascular protection offered by GLP-1 receptor agonists stems from several complementary mechanisms: Anti-inflammatory effects through suppression of CRP, TNF-, and other inflammatory markers Substantial weight reduction, particularly with higher doses of newer agents Blood pressure modulation via direct vascular effects and enhanced natriuresis Improved endothelial function and lipid profiles Renal protective effects, including reduced albuminuria and slowed eGFR decline Though initially established in type 2 diabetes populations, recent evidence from the SELECT trial confirms these benefits extend to non-diabetic patients with obesity and established cardiovascular disease
In other words, TEER is the reflection of the resistance that the epithelium is exerting against ions to cross from the luminal to the basolateral side
